Search results
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| Entry name | UniProt ID | Protein names | Protein classification | Related Diseases | Supporting publications (n) | EVMP confidence score | Download | |
|---|---|---|---|---|---|---|---|---|
| EPHB4 | P54760 | Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) | Cancer-related genesDisease related genesEnzymes | Brain cancer; Cystic/dysplastic kidney disease; Lung cancer; Metastatic meninges neoplasm; Metastatic tumour; Solid tumour/cancer | 2 | 0.25 | ||
| FOLR1 | P15328 | Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18) | Endometrial cancer; Lung cancer; Malaria; Ovarian cancer; Renal cell carcinoma; Solid tumour/cancer | 2 | 0.25 | |||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | Diabetes mellitus; Lung cancer; Lymphoma; Rheumatoid arthritis; Solid tumour/cancer; Transplant rejection | 1 | 0.25 | ||
| FGFR1 | P11362 | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Cancer-related genesCD markersDisease related genes | Acute diabete complication; Acute myeloid leukaemia; Alzheimer disease; Bladder cancer; Breast cancer; Chronic arterial occlusive disease; Colorectal cancer; Coronary atherosclerosis; Endometrial cancer; Epidermal dysplasias; Gram-positive bacterial infection; Idiopathic interstitial pneumonitis; Liver cancer; Lung cancer; Multiple myeloma; Myelodysplastic syndrome; Myeloproliferative neoplasm; Non-alcoholic fatty liver disease; Oesophagitis; Ovarian cancer; Peritoneal cancer; Retina cancer; Solid tumour/cancer; Stomach cancer; Thrombocytopenia; Type 2 diabetes mellitus | 1 | 0.25 | ||
| PGFRB | P09619 | Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) | Cancer-related genesCD markersDisease related genes | Acute diabete complication; Alzheimer disease; Gram-positive bacterial infection; Intracranial injury; Liver cancer; Lung cancer; Multiple myeloma; Myelodysplastic syndrome; Renal cell carcinoma; Solid tumour/cancer; Thrombocytopenia | 1 | 0.25 | ||
| S1PR1 | P21453 | Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363) | Cancer-related genesCD markersFDA approved drug targets | Acne vulgaris; Cardiovascular disease; Crohn disease; Cutaneous lupus erythematosus; Diabetes mellitus; Immune system disease; Liver cancer; Lung cancer; Multiple sclerosis; Postoperative inflammation; Psoriasis; Pyoderma gangrenosum; Retinopathy; Rheumatoid arthritis; Solid tumour/cancer; Ulcerative colitis | 1 | 0.25 | ||
| TIGIT | Q495A1 | T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3) | Cervical cancer; Lung cancer; Non-small-cell lung cancer; Solid tumour/cancer | 1 | 0.25 | |||
| TPBG | Q13641 | Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1) | Predicted membrane proteins | Breast cancer; Lung cancer; Prostate cancer; Solid tumour/cancer | 1 | 0.25 | ||
| MSLN | Q13421 | Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form] | Cancer-related genesDisease related genesPlasma proteins | Breast cancer; Cervical cancer; Endometrial cancer; Fallopian tube cancer; Liver cancer; Lung cancer; Lymphatic vessel/lymph nodes disorder; Mesothelial tumour; Mesothelin positive tumour; Metastatic malignant neoplasm; Metastatic pleura neoplasm; Non-small-cell lung cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer; Pleural mesothelioma; Solid tumour/cancer; Stomach cancer | 5 | 0.38 | ||
| MET | P08581 | Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | Cancer-related genesDisease related genesEnzymes | Alzheimer disease; Biliary tract cancer; Brain cancer; Breast cancer; Cardiovascular disease; Chronic arterial occlusive disease; Colorectal cancer; Fibrosis; Glaucoma; Head and neck cancer; Heart disease; Injury; Liver cancer; Liver disease; Lung cancer; Melanoma; Metastatic lymph node neoplasm; Nasopharyngitis; Non-small-cell lung cancer; Ovarian cancer; Renal cell carcinoma; Sarcoma; Solid tumour/cancer; Stomach cancer; Thyroid cancer | 3 | 0.38 | ||
| NOTC3 | Q9UM47 | Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain] | Cancer-related genesDisease related genesHuman disease related genes | Lung cancer; Pancreatic cancer | 1 | 0.38 | ||
| RET | P07949 | Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] | Cancer-related genesDisease related genesEnzymes | Breast cancer; Colon cancer; Colorectal cancer; Indeterminate colitis; Lung cancer; Mature B-cell lymphoma; Multiple myeloma; Myelodysplastic syndrome; Neurodegenerative disorder; Solid tumour/cancer; Thrombocytopenia; Thyroid cancer | 1 | 0.38 | ||
| S39A6 | Q13433 | Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6) | Metabolic proteinsPredicted membrane proteinsTransporters | Breast cancer; Lung cancer; Non-small-cell lung cancer | 1 | 0.38 | ||
| EPCAM | P16422 | Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) | Cancer-related genesCD markersDisease related genes | Bladder cancer; Breast cancer; Colon cancer; Colorectal cancer; Esophageal cancer; Head and neck cancer; Liver cancer; Lung cancer; Melanoma; Metastatic tumour; Pancreatic cancer; Prostate cancer; Solid tumour/cancer; Stomach cancer | 4 | 0.50 | ||
| NEP | P08473 | Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) | Cancer-related genesCandidate cardiovascular disease genesCD markers | Asthma; Cardiovascular disease; Choreiform disorder; Chronic kidney disease; Chronic pain; Heart disease; Heart failure; Hypertension; Hypotension; Intracranial injury; Kidney failure; Leukaemia; Lung cancer; Mature B-cell lymphoma; Multiple sclerosis; Pain; Sexual dysfunction | 4 | 0.50 | ||
| AA2AR | P29274 | Adenosine receptor A2a | Cancer-related genesFDA approved drug targetsG-protein coupled receptors | Alzheimer disease; Arterial occlusive disease; Choreiform disorder; Chronic obstructive pulmonary disease; Colorectal cancer; Coronary atherosclerosis; Diabetic foot ulcer; General pain disorder; Glaucoma; Heart failure; Hyper-lipoproteinaemia; Hypertension; Lung cancer; Multiple sclerosis; Orthostatic hypotension; Pain; Parkinsonism; Prostate cancer; Radionuclide imaging; Schizophrenia; Solid tumour/cancer; Unspecific substance use disorder; Vasomotor/allergic rhinitis | 3 | 0.50 | ||
| ITB1 | P05556 | Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) | Cancer-related genesCD markersFDA approved drug targets | Brain cancer; Lung cancer; Retinopathy | 3 | 0.50 | ||
| PGFRA | P16234 | Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a) | Cancer-related genesCD markersDisease related genes | Acute myeloid leukaemia; BCR-ABL1-negative chronic myeloid leukaemia; Brain cancer; Breast cancer; Colon cancer; Colorectal cancer; Gastrointestinal stromal tumour; Gram-positive bacterial infection; Kaposi sarcoma; Lung cancer; Malignant digestive organ neoplasm; Mastocytosis; Multiple myeloma; Myelodysplastic syndrome; Pancreatic cancer; Prostate cancer; Solid tumour/cancer; Stomach cancer; Thrombocytopenia | 3 | 0.50 | ||
| AA2BR | P29275 | Adenosine receptor A2b | Alzheimer disease; Asthma; Breathing abnormality; Colorectal cancer; Heart failure; Herpes simplex infection; Hypertension; Ischaemic heart disease; Lung cancer; Multiple sclerosis; Parkinsonism; Solid tumour/cancer; Supraventricular tachyarrhythmia; Type 2 diabetes mellitus | 2 | 0.50 | |||
| PSCA | O43653 | Prostate stem cell antigen | Cancer-related genesPredicted intracellular proteinsPredicted membrane proteins | Non-small-cell lung cancer; Pancreatic cancer; Prostate cancer; Solid tumour/cancer; Stomach cancer | 2 | 0.50 | ||
| ALK | Q9UM73 | ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) | Cancer-related genesCD markersDisease related genes | Adrenal cancer; Breast cancer; Colorectal cancer; Diffuse large B-cell lymphoma; Lung cancer; Lymphoma; Mature T-cell lymphoma; Metastatic tumour; Non-small-cell lung cancer; Solid tumour/cancer | 1 | 0.50 | ||
| EGFR | P00533 | Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) | Cancer-related genesDisease related genesEnzymes | Angina pectoris; Brain cancer; Breast cancer; Cerebral ischaemia; Chronic pain; Colon cancer; Colorectal cancer; Cryptosporidiosis; Diabetic foot ulcer; Diffuse large B-cell lymphoma; Digestive system disease; Esophageal cancer; Gram-positive bacterial infection; Head and neck cancer; Hepatitis virus infection; Hypopharyngeal cancer; Intracerebral haemorrhage; Ischemia; Liver cancer; Lung cancer; Lymphoma; Malignant mesenchymal neoplasm; Mature B-cell leukaemia; Melanoma; Metastatic biliary tract neoplasms; Metastatic lymph node neoplasm; Myelodysplastic syndrome; Nasopharyngeal cancer; Non-small-cell lung cancer; Pancreatic cancer; Psoriasis; Renal cell carcinoma; Skin postprocedural disorder; Solid tumour/cancer; Spinal cord/cranial nerve neoplasm; Stomach cancer; Testicular cancer; Unspecific body region injury; Urethral cancer | 1 | 0.50 | ||
| EGLN | P17813 | Endoglin (CD antigen CD105) | Cancer-related genesCandidate cardiovascular disease genesCD markers | Angiosarcoma; Brain cancer; Breast cancer; Fallopian tube cancer; Gynecologic cancer; Kaposi sarcoma; Liver cancer; Lung cancer; Non-small-cell lung cancer; Ovarian cancer; Peritoneal cancer; Renal cell carcinoma; Retinopathy | 1 | 0.50 | ||
| GPC3 | P51654 | Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit] | Liver cancer; Lung cancer; Metastatic liver/bile duct neoplasm; Solid tumour/cancer | 1 | 0.50 | |||
| I15RA | Q13261 | Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)] | CD markersPredicted intracellular proteinsPredicted membrane proteins | Acute myeloid leukaemia; Bladder cancer; Colorectal cancer; Head and neck cancer; Human immunodeficiency virus disease; Lung cancer; Malignant haematopoietic neoplasm; Multiple myeloma; Pancreatic cancer; Solid tumour/cancer | 1 | 0.50 |